Pancreatic Cancer - Global Market Outlook (2017-2026)

Pancreatic Cancer - Global Market Outlook (2017-2026)

  • Published: August 2019
  • ID: SMRC18497

According to Stratistics MRC, the Global Pancreatic Cancer market is accounted for $1,904.20 million in 2017 and is expected to reach $4,728.19 million by 2026 growing at a CAGR of 10.6% during the forecast period. Advancement of technology in therapeutic devices and expanding prevalence of cancer growth are the factors driving the market. However, accessibility of costly treatment and poor repayment strategies in the emerging regions of the world are some of the factors which may hamper the market growth during the forecast period.

Pancreatic Cancer is a type of cancer that starts in the pancreas. It is a highly lethal disease, for which mortality closely parallels incidence. Most patients with Pancreatic Cancer remain asymptomatic until the disease reaches an advanced stage. There is no standard programme for screening patients at high risk of Pancreatic Cancer. Most Pancreatic Cancers arise from microscopic non-invasive epithelial proliferations within the pancreatic ducts, referred to as pancreatic intraepithelial neoplasias.

Based on the treatment, the biologic therapy has a huge demand due to expanding number of novel upcoming immunotherapies as well as focused cell therapy that treats the cancer with no extreme symptoms and has more number of helpful advantages over the conventional chemotherapies.

By geography, Asia Pacific is growing lucratively during the forecast period owing to the nearness of quickly creating medicinal services innovation, high patient population, and high social insurance use. Additionally, expanding interest for new treatment strategies in nations like India and South Korea is probably going to develop as the quickest developing business sector over the globe.

Some of the key players in the Pancreatic Cancer market include Novartis Ag, Eli Lily and Company, F. Hoffmann-La Roche AG, Pharmacyte Biotech, Inc, Clovis Oncology, Celgene Corporation, Teva Pharmaceutical Industries Ltd., Amgen, Inc., Pfizer, Inc. and Merck & Co., Inc. 

Treatments Covered:
• Biologic Therapy
• Hormone Therapy
• Chemotherapy
• Targeted Therapy
• Surgery
• Radiation Therapy
• Other Treatments

Types Covered:
• Exocrine Pancreas Cancer
• Endocrine Pancreas Cancer

End Users Covered:
• Research Institute
• Hospitals & Clinics
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances.

1 Executive Summary     
       
2 Preface      
 2.1 Abstract     
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology   
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions   
       
3 Market Trend Analysis    
 3.1 Introduction    
 3.2 Drivers     
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats     
 3.6 End User Analysis    
 3.7 Emerging Markets    
 3.8 Futuristic Market Scenario   
       
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry    
       
5 Global Pancreatic Cancer Market, By Treatment  
 5.1 Introduction    
 5.2 Biologic Therapy    
 5.3 Hormone Therapy    
 5.4 Chemotherapy    
 5.5 Targeted Therapy    
 5.6 Surgery     
 5.7 Radiation Therapy    
 5.8 Other Treatments    
       
6 Global Pancreatic Cancer Market, By Type  
 6.1 Introduction    
 6.2 Exocrine Pancreas Cancer   
 6.3 Endocrine Pancreas Cancer   
       
7 Global Pancreatic Cancer Market, By End User  
 7.1 Introduction    
 7.2 Research Institute    
 7.3 Hospitals & Clinics    
 7.4 Other End Users    
       
8 Global Pancreatic Cancer Market, By Geography  
 8.1 Introduction    
 8.2 North America    
  8.2.1 US    
  8.2.2 Canada    
  8.2.3 Mexico    
 8.3 Europe     
  8.3.1 Germany    
  8.3.2 UK    
  8.3.3 Italy    
  8.3.4 France    
  8.3.5 Spain    
  8.3.6 Rest of Europe   
 8.4 Asia Pacific    
  8.4.1 Japan    
  8.4.2 China    
  8.4.3 India    
  8.4.4 Australia    
  8.4.5 New Zealand   
  8.4.6 South Korea   
  8.4.7 Rest of Asia Pacific   
 8.5 South America    
  8.5.1 Argentina   
  8.5.2 Brazil    
  8.5.3 Chile    
  8.5.4 Rest of South America  
 8.6 Middle East & Africa   
  8.6.1 Saudi Arabia   
  8.6.2 UAE    
  8.6.3 Qatar    
  8.6.4 South Africa   
  8.6.5 Rest of Middle East & Africa  
       
9 Key Developments     
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers   
 9.3 New Product Launch   
 9.4 Expansions    
 9.5 Other Key Strategies   
       
10 Company Profiling   
 
 10.1 Novartis Ag    
 10.2 Eli Lily and Company    
 10.3 F. Hoffmann-La Roche AG   
 10.4 Pharmacyte Biotech, Inc   
 10.5 Clovis Oncology    
 10.6 Celgene Corporation   
 10.7 Teva Pharmaceutical Industries Ltd.   
 10.8 Amgen, Inc.    
 10.9 Pfizer, Inc.     
 10.10 Merck & Co., Inc.     


List of Tables      
1 Global Pancreatic Cancer Market Outlook, By Region (2016-2026) (US $MN) 
2 Global Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN) 
3 Global Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN) 
4 Global Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN) 
5 Global Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN) 
6 Global Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN) 
7 Global Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN) 
8 Global Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN) 
9 Global Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN) 
10 Global Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN) 
11 Global Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN) 
12 Global Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN) 
13 Global Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN) 
14 Global Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN) 
15 Global Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN) 
16 Global Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN) 
17 North America Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN) 
18 North America Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN) 
19 North America Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN) 
20 North America Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN) 
21 North America Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN) 
22 North America Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN) 
23 North America Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN) 
24 North America Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN) 
25 North America Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN) 
26 North America Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN) 
27 North America Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN) 
28 North America Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN) 
29 North America Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN) 
30 North America Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN) 
31 North America Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN) 
32 North America Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN) 
33 Europe Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN) 
34 Europe Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN) 
35 Europe Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN) 
36 Europe Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN) 
37 Europe Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN) 
38 Europe Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN) 
39 Europe Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN) 
40 Europe Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN) 
41 Europe Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN) 
42 Europe Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN) 
43 Europe Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN) 
44 Europe Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN) 
45 Europe Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN) 
46 Europe Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN) 
47 Europe Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN) 
48 Europe Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN) 
49 Asia Pacifc Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN) 
50 Asia Pacifc Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN) 
51 Asia Pacifc Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN) 
52 Asia Pacifc Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN) 
53 Asia Pacifc Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN) 
54 Asia Pacifc Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN) 
55 Asia Pacifc Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN) 
56 Asia Pacifc Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN) 
57 Asia Pacifc Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN) 
58 Asia Pacifc Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN) 
59 Asia Pacifc Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN) 
60 Asia Pacifc Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN) 
61 Asia Pacifc Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN) 
62 Asia Pacifc Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN) 
63 Asia Pacifc Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN) 
64 Asia Pacifc Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN) 
65 South America Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN) 
66 South America Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN) 
67 South America Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN) 
68 South America Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN) 
69 South America Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN) 
70 South America Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN) 
71 South America Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN) 
72 South America Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN) 
73 South America Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN) 
74 South America Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN) 
75 South America Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN) 
76 South America Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN) 
77 South America Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN) 
78 South America Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN) 
79 South America Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN) 
80 South America Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN) 
81 Middle East & Africa Pancreatic Cancer Market Outlook, By Country (2016-2026) (US $MN) 
82 Middle East & Africa Pancreatic Cancer Market Outlook, By Treatment (2016-2026) (US $MN) 
83 Middle East & Africa Pancreatic Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN) 
84 Middle East & Africa Pancreatic Cancer Market Outlook, By Hormone Therapy (2016-2026) (US $MN) 
85 Middle East & Africa Pancreatic Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN) 
86 Middle East & Africa Pancreatic Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN) 
87 Middle East & Africa Pancreatic Cancer Market Outlook, By Surgery (2016-2026) (US $MN) 
88 Middle East & Africa Pancreatic Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN) 
89 Middle East & Africa Pancreatic Cancer Market Outlook, By Other Treatments (2016-2026) (US $MN) 
90 Middle East & Africa Pancreatic Cancer Market Outlook, By Type (2016-2026) (US $MN) 
91 Middle East & Africa Pancreatic Cancer Market Outlook, By Exocrine Pancreas Cancer (2016-2026) (US $MN) 
92 Middle East & Africa Pancreatic Cancer Market Outlook, By Endocrine Pancreas Cancer (2016-2026) (US $MN) 
93 Middle East & Africa Pancreatic Cancer Market Outlook, By End User (2016-2026) (US $MN) 
94 Middle East & Africa Pancreatic Cancer Market Outlook, By Research Institute (2016-2026) (US $MN) 
95 Middle East & Africa Pancreatic Cancer Market Outlook, By Hospitals & Clinics (2016-2026) (US $MN) 
96 Middle East & Africa Pancreatic Cancer Market Outlook, By Other End Users (2016-2026) (US $MN) 

 

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials